Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy-Reference-Cited by-同舟云学术

Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy

Published:2016-08 Issue: Volume:24 Page:57-62
ISSN:1389-9457
Container-title:Sleep Medicine
language:en
Short-container-title:Sleep Medicine

Author:

Black Jed,Swick Todd,Bogan Richard,Lai Chinglin,Carter Lawrence P.

Funder

Jazz Pharmaceuticals, Inc.

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Clinical features, diagnosis and treatment of narcolepsy;Ahmed;Clin Chest Med,2010

2. The international classification of sleep disorders – third edition (ICSD-3);American Academy of Sleep Medicine,2014

3. Challenges in diagnosing narcolepsy without cataplexy. A consensus statement;Baumann;Sleep,2014

4. Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency;Andlauer;JAMA Neurol,2013

5. Nocturnal sleep dynamics identify narcolepsy type 1;Pizza;Sleep,2015

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of modafinil compared to γ-hydroxybutyrate in the treatment of narcolepsy;F1000Research;2023-09-08

2. The Treatment of Parkinson’s Disease with Sodium Oxybate;Current Molecular Pharmacology;2023-08

3. Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1;New England Journal of Medicine;2023-07-27

4. Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial;SLEEP;2023-05-29

5. Comparative Efficacy and Safety of Multiple Wake-Promoting Agents for the Treatment of Excessive Daytime Sleepiness in Narcolepsy: A Network Meta-Analysis;Nature and Science of Sleep;2023-04